Movfor contains Molnupiravir 200 mg which belongs to COVID 19 Management therapy that is used in the treatment of COVID-19 in adult patients.
Movfor is an investigational, orally bioavailable medicine indicated for restricted emergency use in India to treat adult patients affected with COVID 19, with SpO2>93%, or who have a high risk of disease progression or hospitalization.
Movfor 200MG Capsules has its active agent as Molnupiravir which is a potent ribonucleoside analog that inhibits the replication of multiple RNA viruses, including SARS-CoV2, that causes COVID 19. It is active in several models of SARS-CoV-2 like viral respiratory disease caused by a novel Coronavirus.
